406 related articles for article (PubMed ID: 36179876)
1. Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.
Noya-Riobó MV; Miguel CÁ; Soriano DB; Brumovsky PR; Villar MJ; Coronel MF
Exp Neurol; 2023 Jan; 359():114232. PubMed ID: 36179876
[TBL] [Abstract][Full Text] [Related]
2. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
3. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
[TBL] [Abstract][Full Text] [Related]
4. Sex-related differences in oxaliplatin-induced changes in the expression of transient receptor potential channels and their contribution to cold hypersensitivity.
Miguel CÁ; Noya-Riobó MV; Brumovsky PR; Villar MJ; Coronel MF
Neurosci Lett; 2022 Sep; 788():136863. PubMed ID: 36067900
[TBL] [Abstract][Full Text] [Related]
5. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
7. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
Thomas A; Okine BN; Finn DP; Masocha W
Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model.
Haranishi Y; Hara K; Terada T
Pharmacol Rep; 2021 Jun; 73(3):820-827. PubMed ID: 33783763
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the anandamide metabolism in the development of neuropathic pain.
Malek N; Kucharczyk M; Starowicz K
Biomed Res Int; 2014; 2014():686908. PubMed ID: 25276812
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
[TBL] [Abstract][Full Text] [Related]
11. Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain.
Mitrirattanakul S; Ramakul N; Guerrero AV; Matsuka Y; Ono T; Iwase H; Mackie K; Faull KF; Spigelman I
Pain; 2006 Dec; 126(1-3):102-14. PubMed ID: 16844297
[TBL] [Abstract][Full Text] [Related]
12. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
[TBL] [Abstract][Full Text] [Related]
13. Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors: Implications for Novel Treatment Strategies in Osteoarthritis.
Mlost J; Kostrzewa M; Malek N; Starowicz K
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364174
[TBL] [Abstract][Full Text] [Related]
14. JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.
Khasabova IA; Yao X; Paz J; Lewandowski CT; Lindberg AE; Coicou L; Burlakova N; Simone DA; Seybold VS
Pharmacol Res; 2014 Dec; 90():67-75. PubMed ID: 25304184
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid activation of CB
Sun L; Tai L; Qiu Q; Mitchell R; Fleetwood-Walker S; Joosten EA; Cheung CW
Eur J Pain; 2017 May; 21(5):804-814. PubMed ID: 28107590
[TBL] [Abstract][Full Text] [Related]
16. Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis.
Sanchez AM; Cioffi R; Viganò P; Candiani M; Verde R; Piscitelli F; Di Marzo V; Garavaglia E; Panina-Bordignon P
Reprod Sci; 2016 Aug; 23(8):1071-9. PubMed ID: 26887427
[TBL] [Abstract][Full Text] [Related]
17. Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation.
Mulpuri Y; Marty VN; Munier JJ; Mackie K; Schmidt BL; Seltzman HH; Spigelman I
Neuropharmacology; 2018 Sep; 139():85-97. PubMed ID: 29981335
[TBL] [Abstract][Full Text] [Related]
18. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
Booker L; Kinsey SG; Abdullah RA; Blankman JL; Long JZ; Ezzili C; Boger DL; Cravatt BF; Lichtman AH
Br J Pharmacol; 2012 Apr; 165(8):2485-96. PubMed ID: 21506952
[TBL] [Abstract][Full Text] [Related]
19. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.
Aly E; Masocha W
IBRO Neurosci Rep; 2021 Jun; 10():109-118. PubMed ID: 34179865
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of endocannabinoids.
Biernacki M; Skrzydlewska E
Postepy Hig Med Dosw (Online); 2016 Aug; 70(0):830-43. PubMed ID: 27516570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
